Encompass Health Corporation Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Encompass Health Corporation (EHC) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $400.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-26
- Encompass Health Corporation valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2011-12-31 was $54.40M.
- Encompass Health Corporation valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2011-03-31 was $7.00M.
- Encompass Health Corporation valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $400.00K.
- Encompass Health Corporation valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was -$7.40M.
- Encompass Health Corporation valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was -$7.40M.
- Encompass Health Corporation valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was -$7.30M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 9 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | $400.00K 10-K · filed 2026-02-26 | |||
| 2024-12-31 | -$7.40M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | -$7.40M 10-K · filed 2025-02-28 | |||
| 2022-12-31 | -$7.30M 10-K · filed 2024-02-28 | |||
| 2021-12-31 | -$3.10M 10-K · filed 2023-02-27 | |||
| 2020-12-31 | $7.80M 10-K · filed 2022-02-25 | |||
| 2019-12-31 | $4.70M 10-K · filed 2021-02-26 | |||
| 2018-12-31 | -$2.10M 10-K · filed 2020-02-27 | $2.10M 10-K · filed 2019-02-27 | ||
| 2017-12-31 | $7.90M 10-K · filed 2020-02-27 | |||
| 2016-12-31 | -$300.00K 10-K · filed 2019-02-27 | $300.00K 10-K · filed 2017-02-22 | ||
| 2015-12-31 | $4.60M 10-K · filed 2018-02-28 | |||
| 2014-12-31 | -$7.70M 8-K · filed 2017-09-19 | $7.70M 10-K · filed 2015-03-02 | ||
| 2013-12-31 | -$9.10M 10-K · filed 2016-02-25 | $9.10M 10-K · filed 2014-02-20 | ||
| 2012-12-31 | $10.50M 10-K · filed 2015-03-02 | |||
| 2011-12-31 | $54.40M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $62.40M 10-K · filed 2014-02-20 | ||
| 2011-09-30 | $8.00M 10-Q · filed 2011-11-04 | |||
| 2011-03-31 | $7.00M 10-Q · filed 2011-08-04 | |||
| 2010-12-31 | $825.40M 10-K · filed 2013-02-19 | $825.00M 10-Q · filed 2011-08-04 | ||
| 2009-12-31 | $76.90M 8-K · filed 2012-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |